Parathyroid hormone Other names: Parathyrin Parathormone

Therapeutic indications

Parathyroid hormone is indicated for:

Chronic hypoparathyroidism

Population group: only adults (18 - 65 years old)

Parathyroid hormone is indicated as adjunctive treatment of adult patients with chronic hypoparathyroidism who cannot be adequately controlled with standard therapy alone.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Parathyroid hormone is contraindicated in the following cases:

Radiation therapy to the skeleton

Radiotherapy to bone

Patients with skeletal malignancies, patients with bone metastases

at least one of
Malignant neoplasm of skeletal system
Secondary malignant neoplasm of bone

Patients at increased baseline risk for osteosarcoma

Osteitis deformans

Elevations of bone-specific alkaline phosphatase

Alkaline phosphatase bone isoenzyme raised

Pseudohypoparathyroidism

Pseudohypoparathyroidism

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: NATPAR Powder and solvent for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈